BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction | MicrobiomeTrials← Back to trialsNCT02880618
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
RecruitingOBSERVATIONAL
Trial Details
Start: 2016-12-13Est. Completion: 2027-07
Enrollment target: 500 participants Locations- Albertinen-Krankenhaus, Hamburg, Free and Hanseatic City of Hamburg, Germany
- Herzzentrum Bad Oyenhausen, Bad Oeynhausen, Germany
- Berlin Charité & Deutschen Herzzentrum Berlin, Berlin, Germany
- Charité Campus Virchow Klinikum, Berlin, Germany
- Immanuel Klinikum Bernau Herzzentrum Brandenburg, Bernau, Germany
- Medizinisches Versorgungszentrum am Küchwald GmbH, Chemnitz, Germany
- Universitätsklinikum Köln Herzzentrum, Cologne, Germany
- Lippe Klinikum, Detmold, Germany
- Dresden Friedrichstadt, Dresden, Germany
- Herzzentrum Dresden - Interventionelle Kardiologie, Dresden, Germany
- Herzzentrum Dresden, Elektrophysiologie, Dresden, Germany
- Uniklinik Frankfurt, Frankfurt, Germany
- Universitätsklinikum Gießen und Marburg, Giessen, Germany
- Herzzentrum Göttingen, Göttingen, Germany
- Asklepios Klinik Altona, Hamburg, Germany
- St. Barbara Klinik Hamm, Hamm, Germany
- Medizinische Hochschule Hannover, Hanover, Germany
- Kardiologie im Klinikum Ingolstadt, Ingolstadt, Germany
- Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
- Herzentrum Lahr, Lahr, Germany
- Universitätsklinikum Leipzig, Leipzig, Germany
- Leipzig St. Georg, Leipzig, Germany
- Universitätsklinik Mainz, Mainz, Germany
- Clemenshospital Münster, Münster, Germany
- St. Vincenz-Krankenhaus, Paderborn, Germany
- Universitätsklinikum Regensburg, Regensburg, Germany
- Marienkrankenhaus Siegen, Siegen, Germany
- Krankenhaus & MVZ Maria-Hilf Stadtlohn GmbH, Stadtlohn, Germany
- Klinikum Tuttlingen, Tuttlingen, Germany
- Fondazione di Ricerca e Cura "Giovanni Paolo II", Campobasso, Italy
Other microbiome trials you might be interested in
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade AstrocytomaMetastatic Low Grade GliomaWHO Grade 1 GliomaWHO Grade 2 Glioma
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincr…
Birmingham, United StatesEst. completion Dec 31, 2030
Acute-On-Chronic Liver FailureSepsis
This study aims to evaluate the efficacy and safety of the double plasma cytokine adsorption system with sequential low-…
Guangzhou, China
Est. completion Oct 31, 2027